Fill - Free fillable Vhap-workbook-for-stakeholders STAKEHOLDERS’ WORKBOOK PDF form





Staple

here

Staple

here

Staple

here

STAKEHOLDERS’ WORKBOOK 

Exploring Vital Roles 

and Opportunities

to Break the Silence



C ONTINUING TO C OMBAT THE  S ILENT  E PIDEMIC  OF  V IRAL H EPATITIS

Action Plan for the Prevention, Care,

& Treatment of Viral Hepatitis

Updated 2014‐2016



Developed by the Office of HIV/AIDS and Infectious Disease Policy

for planning purposes only 



        



          

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence

     

    

 



      

               

 



   

 

  

 



 



C ONTINUING TO C OMBAT THE S ILENT E PIDEMIC OF V IRAL H EPATITIS

Action Plan for the Prevention, Care,

& Treatment of Viral Hepatitis

Updated 2014‐2016

Exploring Vital Roles and Opportunities for Stakeholders

Background

Buildingonthesuccessofthenation’sfirstcomprehensivecross‐agencyactionplan,releasedin2011,

Combating the Silent

Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care, & Treatment of

Viral Hepatitis,theU.S.Department ofHealth and Human Services(HHS)in collaborationwiththeU.S.

DepartmentsofHousingandUrban Development (HUD),Justice(DOJ),andVeteransAffairs(VA)

developedandreleased a 3‐yearupdate ofthat planin April2014.

Theupdated ActionPlancontinue

s topursueitsfouroverarching nationalgoals by 2020:

 Increase the proportion ofpersonswhoare aware oftheirHBVinfection from

33percent to66percent,

 Increase the proportion ofpersonswhoare aware oftheirHCVinfection from

45percent to66percent,

 Reduce the number of new cases ofHCV infectionby25percent,and

 Eliminate mother‐to‐childtransmissionof HBV.

The updated plandet

ails morethan 150 actions organized around sixpriorityareasthatagencies

andoffices fr

om acrossthefour federaldepartments willpursuebetween 2014 and 2016 to achieve

these goals.

Theupdated ViralHepati

tisActionPlan,orAction Plan,underscoresthatitsnationalgoalscannot be

achievedthroughfederalactionalone.Activeinvolvement,andinnovation ofabroadmix ofstakeholders

fromvarioussectors,bot

hpublicandprivate,isessential.S

updateoftheActionPlanandpl

takeholderswerestrongl

nation

updatedpla

algoal

shoulde

forthepreventio

xplicitlyembr

ayedacriticalrol

cethe

n,diagnosis,care,andtreat

vitalcontributio

einprovidi

s

of

tofviral

input

result,theupdateddocumentcont

various

into

ainsaninitiallistofopportunitiesthats

hep



ysupportiveofthe

heprocess.Allagreedth

atth

stakeh

oldersinachi

e

evingthe

takeholder

atitisinth

sfrom

eUnitedStat

varioussectors

es.Asa

canundertaketocompl



ementthefederaleffortsde tailedinthe plan.



          

   



 



 



 



 



 

Detailing Opportunities for Stakeholders

The plan providesa framework andfocusaroundwhichallkeystakeholderscanengageto strengthenthe

nation’sresponseto viralhepatitis and seeksto leverageopportunitiestoimprovethe coordinationofviral

hepatitisactivitiesacrossallsectors.Thisworkbookwascreatedtoassistyouinidentifyingadditional

innovativeandactionable (specificand detailed)opportunities toadvanceeachoftheActionPlan’ssix

priorityareas.These may be stepsbyindividualorganizations, actionsthatengageaparticular

stakeholder’snetworks,oran entire stateor sectorinactions thatcomplement,amplify,orextendthe

actionsdetailedinthe plantowhichthe federalpartnershave committed.Workingtogether,various

stakeholders canimprove ournation’s responseto viralhepatitis and achieve the plan’slifesavinggoals.

Instructions

StakeholderinvolvementisessentialtoensuringtheoverallsuccessoftheActionPlan. Weencourage you

andyourcolleaguesto create opportunitiesto talk through ideas,potentialactivities,challenges,tools,

resources,andpartnershipsrelatedtoeachpriorityarea.

To facilitate discussion,eachpriorityareasectionincludesa brief,simplesummary,thegoalsfromthe

ActionPlan,sampleopportunities forstakeholders,andinitial discussionquestionsbased onthe goals.

Examplesofopportunitiesaredescribedforindividuals,health professionalsandprofessional

organizations,andcommunity‐based,patient,andadvocacygroups.For eachquestion, pleaseidentify

thefollowing:

 Specificactionsthat you,yourorganization,or otherorganizationscan take to

helpimplementthe ActionPlan;

 Specificpartnersthatshouldbe engaged;and

 Keymessagesand/orexisting,effectivemessages.

Atthe end oftheworkbook,wehaveincludedasamplehepatitis planningsheettofurthersupporteffective

collaboration.Thesampleplanningsheetprovidesan opportunitytobrainstormtimeframesand

measuresfor progress foreachactivity.

ThroughimplementationoftheAction Plan,we have foundthat partnershipandcollaborationhavebeen

themosteffectivestrategiesto addressviralhepatitis.Werecommendreachingouttoabroadrangeof

potentialpartnersinthepublicandprivatesectors including: departments of health(state andlocal),

academicresearchers and programs, community organizationsof allkinds,advocates,professional

associations, healthcareprovidergroups,pharmaceutical anddiagnosticscompanies,hospitals,businesses,

workforcewellnessprograms,correctionsprograms,andothers.

Theideasgeneratedfromthisworkbookcanbesharedwithcolleagueswithinorganizations,workgroups

orcoalitions, communityplanning groups,andotherstakeholderstoidentifyprioritiesandnextstepsto

helpguideyourwork. Theaction steps can be used ina variety ofways suchasprogram planning, coalition

building,orevenas thetemplateforanAction Plan of yourown.

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



          



   

 



      

                    

                   

              

    

  



  

 



    

 



 

           

    

 

  



     

  

 

Priority Area 1:

Educating

Providers and Communities

to Reduce Viral Hepatitis‐related

Health Disparities

Confront viral hepatitis by breaking the silence.

For too long, there has been silence on viral hepatitis. In order to achieve the goals of the Viral Hepatitis Action

Plan, we must work to break this deadly silence on viral hepatitis both among health care providers, as well as

other allies working with heavily affected populations, while addressing low levels of awareness of viral

hepatitis in the general public.

GOAL 1.1

BuildaU.S.healthcareworkforcepreparedtopreventanddiagnoseviralhepatitisandprovide

careandtreatmenttoinfectedpersons.

GOAL 1.2

Decrease healthdisparities by educatingcommunitiesaboutthe benefitsofviralhepatitis

prevention,care,andtreatment.

Examples of Opportunities for Stakeholders

Individuals can:

 Take the CDC Viral HepatitisRiskAssessmentand sharetheAssessmentwithfamily,friends,

colleagues,andcommunitymembers.

 Askhealthcareprovidersiftestingand/orvaccinationis recommended.

 Learn more about viral hepatitisand gettested by attendingeventsonNationalHepatitisTesting

Day (May 19) andWorld HepatitisDay (July 28).

Medical, nursing, public health and other health professionals and professional organizations, associations,

schools and training programs can:

 Helpdisseminateprofessionaltraining toolsandmaterials.

 Encourage training of peers and colleagueswithfreeCMEs(such as at www.hepwebstudy.org.)

 UseCDC’s onlineriskassessment todetermine ifclientsneedhepatitisvaccination ortesting.

 OrderCDC’spostersordownload educational fact sheetsforuse withpatients.

Community‐based, patient, and advocacy groups can:

 UseCDC’s hepatitiscampaign materialstohelpspreadtheword about theimportance ofgetting

testedforviralhepatitis.

 Holdregular hepatitis testing events,andparticipateinNational Testing Day on May 19

.

 Continue to buildcoalitionstoexpand theabilitytoreach populationsmostimpactedby

viralhepatitis.

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



          

  



      

                  

  

                

       

              

             

     



              



Priority Area 1

EducatingProvidersandCommunities toReduceViralHepatitis‐relatedHealthDisparities

Confront viral hepatitis by breaking the silence.

What

types of training can your organization do and/or promote? What is the most effective format and who are

your target audiences?

Related Goal: Build a U.S. health care workforce prepared to prevent and diagnose viral hepatitis and provide

care and treatment to infected persons (Goal 1.1).

What activities can you conduct to increase community awareness about health disparities in viral hepatitis?

Related Goal: Decrease health disparities by educating communities about the benefits of viral hepatitis

prevention, care, and treatment (Goal 1.2).

Information, partners, materials, or tools that would be helpful in Priority Area 1 efforts include:

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



          



  

     

    



     

                   

                 

              



              

               

              

 

          

  

   

  

  

  

  

 

  

 

  



  

           

    



     



 



Priority Area 2:

Improving Testing, Care, and Treatment to

Prevent Liver Disease and Cancer

Take full advantage of existing tools.

Providers at every level in the health care system can play a critical role in meeting the needs of the

millions of people at risk for and living with viral hepatitis. However, not all providers are prepared to

address these needs and missed opportunities to prevent, diagnose, treat, and care for persons with

viral hepa

titis have resulted in preventable morbidity and mortality. In order to achieve the goals of

the Viral Hepatitis Action Plan, we must fully utilize existing training, clinical care tools and policies,

address unmet needs, and develop model programs to expand health care provider capacity to provide

high‐quality viral hepa

titis prevention, care, and treatment in primary care and other settings.

GOAL 2.1

Identifypersonsinfected withviralhepatitisearly inthe course oftheirdisease.

GOAL 2.2

Linkandreferpersonsinfected withviralhepatitistocare and treatment.

GOAL 2.3

Improve accesstoand qualityofcare andtreatment forpersons infectedwithviralhepatitis.

GOAL 2.4

Advanceresearchtofacilitateviralhepatitispreventionandenhancecare andtreatment for

infected persons.

Opportunities for Stakeholders

Individuals can:

 Learn about andpromote theCDC ViralHepatitisRiskAssessment anddiscusstheresultant

recommendationswith providers.

 Learn about currentantiviraltherapiesandshare theinformationwithchronicallyinfectedfriends

andfamily members.

Medical, nursing, public health and other health professionals and professional organizations, associations,

schools and training programs can:

 Identifyopportunitiesto increaseproviderawarenessand utilizeexistingtraining,tools,and

modelprograms.

 Adoptviralhepatitistestingandcarerecommendationsinclinicalsettings.

 Ensure followupandlinkageto carewhenconductingviralhepatitistesting.

Community‐based, patient and advocacy groups can:

 Developculturallyandlinguisticallyrelevanthealthliteracy toolsandmaterialsforpopulations

atriskforhepatitisBandC.

 Mobilize communities aboutthe silentepidemic of viralhepatitisandthe threatsof an

unaddressedepidemic.

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



          

  



     

                   

      

                

               

             

                  

                 

  

               

  

              



               



              



Priority Area 2

Improving Testing, Care,and TreatmenttoPreventLiver Disease and Cancer

Take full advantage of existing tools.

What are the best ways to identify persons with chronic viral hepatitis who do not know they are infected? What

can your organization do to promote this?

Related Goal: Identify persons infected with viral hepat itis early in the course of their disease (Goal 2.1).

How can your organization effectively link and re fe r pe rs ons diagnosed with viral hepatitis to care and treatment?

Related Goal: Link and refer persons infected with vira l hepatitis to care and treatment (Goal 2.2).

What activities/strategies could improve access to and quality of care and treatment for persons infected with

viral hepatitis? Are there specific activities/strategies for special populations and/or the communities you serve?

Related Goal: Improve access to and quality of care and treatment for persons infect ed with viral hepatitis (Goal 2.3).

Are there ways you can work with researchers to come up with strategies to improve viral hepatitis prevention,

care, and treatment?

Related Goal: Advance rese arch to facilitate viral hepatitis prevention and enhance care and treatment for in fected

persons (Goal 2.4).

Information, partners, materials or tools that would be helpful in Priority Area 2 efforts include:

What activities can your organization or other nonfederal partners do to decrease health disparities in viral hepat itis?

Information, materials or tools that would be helpful to have in order to this include:

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



          



  



   

    



         

             

               

                  

  

              

   

  

 

  

 

  

  

  

      



  



           

   

 



     

 



Priority Area 3:

Strengthening Surveillance to Detect

Viral Hepatitis Transmission and Disease

Collect accurate and timely information to get the job done.

Surveillance and other health data are necessary to shape and direct effective viral hepatitis

prevention, care, and treatment efforts. Data can also play an important role in making decisions on

how resources can best be allocated to meet the needs of populations at risk for or infected with HBV

or HCV. In or

der to achieve the goals of the Viral Hepatitis Action Plan, partners across various sectors

must build new relationships, identify opportunities to utilize HIT, and maximize our use of available

data for informed decision‐making.

GOAL 3.1

Monitorviralhepatitis‐associatedhealthdisparities,transmission,anddisease.

GOAL 3.2

Monitorprovisionandimpactof viralhepatitisprevention,care, andtreatmentservices.

GOAL 3.3

Develop and implement newtechnologiesandlaboratoryprocedurestoimprove

viralhepatitissurveillance.

Opportunities for Stakeholders

Medical, nursing, and other medical professionals can:

 Reportviral hepatitisinaccordancewithpublichealthandcommunicablediseaserequirements.

 Collaboratewithpublichealthauthoritiestoimprovesurveillancedatacompleteness andquality.

 Useelectronichealth recordtechnologyto assessandevaluate theimpact ofviralhepatitisand

relatedservices.

 Establishpatientregistries toevaluate andimprove patientmanagementand clinicalprocesses.

Public health, research, and other health professionals and professional organizations, associations, schools

and training programs can:

 Develop more detailed informationaboutpopulation‐specifichealthdisparitiesinviralhepatitis

prevention,diagnosis, care,andtreatment.

 Contribute toresearchandthedevelopmentofimprovedtesting proceduresandtechnologies.

 Supportstatesurveillanceprojects and epidemiologicalinvestigationstohelpunderstandthe

characteristicsandneedsof the emerginghepatitisCepidemic amongyoungpeoplewho injectdrugs.

Community‐based, patient and advocacy groups can:

 Promoteandsupportresearchondeterminingthe prevalence ofhepatitis among homelessand

otherat‐riskindividualsandfamilies.

 Developplain‐languagedocuments basedonresearchanddisseminate to communities.

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



          

  

         

            

           

               

        

               

                   



             

  



              



Priority Area 3

StrengtheningSurveillancetoDetectViralHepatitisTransmissionandDisease

Collect accurate and timely information to get the job done.

How can your program contribute to the monitoring of viral hepatitis‐associated health disparities?

Related Goal: Monitor viral hepatitis‐associated health disparities, transmission, and disease (Goal 3.1).

What opportunities are there for your organization to monitor or provide information about the provision and

impact of viral hepatitis prevention, care, and treatment services?

Related Goal: Monitor provision and impact of viral hepatitis prevention, care, and treatment se rv ices (G oal 3.2).

What new technologies or lab services would improve your ability to serve people living with or at risk for viral

hepatitis?

Related Goal: Develop and implement new technologies and laboratory procedures to improve viral hepatitis

surveillance (Goal 3.3).

Information, partners, materials or tools that would be helpful in Priority Area 3 efforts include:

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



          



  



  

  



           

                

                   

    

  

 

  

 

  

 

  

 

           

   



 



 



     

 



Priority Area 4:

Eliminating Transmission of

Vaccine‐Preventable Viral Hepatitis

Take full advantage of vaccines that can prevent hepatitis A and B.

Focused efforts to increase the number of persons who receive hepatitis A and B vaccination will lead

to further reductions in the burden of hepatitis A and B in the United States and to the elimination of

mother‐to‐child transmission of hepatitis B.

GOAL 4.1

Eliminatemother‐to‐childtransmissionofhepatitisB.

GOAL 4.2

Achieve universal hepatitis A andBvaccinationfor vulnerable adultsandyouth.

GOAL 4.3

Designandtestneworimproved viralhepatitisvaccines,anddeterminetheindicationsfor

theiroptimaluse.

Opportunities for Stakeholders

Individuals can:

 AskhealthcareprovidersifvaccinationforHAV and/orHBVis recommendedfortheirparticular

healthcare needs.

 Request atestforHBV if it’srecommendedby the CDC ViralHepatitisRiskAssessment.

Public health, research, and other health professionals and professional organizations, associations, schools

and training programs can:

 Conducthealthcareproviderand consumer educationon HBVscreening for pregnantwomen and

ensuringneonatesreceiveabirthdose ofhepatitis Bvaccine.

 Ensurethatinstitutional policiesincludeHBVscreeningforexpectantwomenandprompt

administrationof the birthdoseof hepatitisBvaccineto infants.

 Complete the three‐dose seriesandreceivepost‐vaccination testingforinfantsborn to

HBsAg‐positivewomen.

 Initiate orenhancevaccination inclinicalsettings serving prioritypopulations.

 Investinresearchonneworimprovedvaccines.

Community‐based, patient and advocacy groups can:

 Disseminate federally developedrecommendations, guidelines,andcampaign materials to

professional,institutional, consumer,andcommunitynetworks.

 Collaboratewithpublichealthandcommunitystakeholderstoeducate,screen,andvaccinate

prioritypopulations.

 Educate the publicandhealthcareprovidersabout thepreventivebenefitsandcoverageprovisions

ofthe Affordable Care Act andtheirimplicationsforimproved hepatitisAandB vaccinecoverage.

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



          

  

 

           

              

         

                

       

               

              

 

                

   



              



Priority Area 4

Eliminating TransmissionofVaccine‐PreventableViralHepatitis

Take full advantage of vaccines that can prevent hepatitis A and B.

What activities can your organization undertake to raise

awareness about and/or reduce perinatal hepatitis B?

Related Goal: Eliminate mother‐to‐child transmission of hepatitis B (Goal 4.1).

How can your organization increase

hepatitis A and B vaccination rates for vulnerable adults and youth? (May

be different for different target audiences‐ AAPI, PWID, others)

Related Goal: Achieve universal hepatitis A and B vaccination for vulnerable adults and youth (Goal 4.2).

What can your organization do to support H epatitis C vaccine development and/or preparedness at the

community level?

Related Goal: Design and test new or improved viral hepatitis vaccines, and determine the indications for their

optimal use. (Goal 4.3)

Information, partners, materials or tools that would be helpful in Priority Area 4 efforts include:

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



          



  

   

  



         

            

                

             

      

       

     

  





  

  

  



  



  

 

   

           

   

     

 



    



Priority Area 5:

Reducing Viral Hepatitis Associated

with Drug Use

Stop the spread of viral hepatitis associated with drug use.

A broad cross‐section of public‐and private‐sector partners is increasingly alarmed by the emergence

of an epidemic of hepatitis C infection among young people who inject drugs, both male and female,

primarily in rural and suburban settings, who started prescription opioid use before transitioning to

heroin injection. There is an urgent need for research, surveillance, and prevention strategies that

interrupt viral hepatitis transmission in order to cu

rb rising incidence rates in young people and

others who use and/or inject drugs.

GOAL 5.1

Ensurethatpersonswho injectdrugshave accessto viralhepatitisprevention,care,and

treatment services.

GOAL 5.2

Develop and mobilize communityresourcestopreventviralhepatitiscausedbyinjection

druguse.

GOAL 5.3

Expandaccess toanddeliveryof hepatitisprevention,care,andtreatmentservicesin

correctionalsettings.

GOAL 5.4

Advanceresearchtoimprovepreventionofviralhepatitisamong personswhouse drugs.

Opportunities for Stakeholders

Individuals can:

 Learn the risksof viralhepatitisassociatedwithinjectiondrug useandstrategies toprevent

transmission.

 Share accuratefactsabout viral hepatitiswithfriends,peers, and family members.

Public health, research, and other health professionals and professional organizations, associations, schools

and training programs can:

 Identifysignificant gapsin services,socialsupportsandother needsof PWID atthe communitylevel.

 Promotetheavailabilityoftrainingopportunitiesforprovidersandotherswhoworkcloselywith

thoseatriskforinitiatinginjectiondrug use,PWID,andpeopleincorrectionalfacilities.

Community‐based, patient and advocacy groups can:

 Adviseinthe developmentoftrainingtoolsandcurriculaforworkingwith PWID andotherdrug users.

 Addressthe needsof youngpeopleinfectedwith andaffectedby HCV(since youngPWID may not

prioritizehepatitisCprevention,interventionswillneedto holisticallyaddresstheirotherpriorities,

focusingon basicneeds andage‐appropriatehealthcare anddrug treatment, integrating HCV

preventioninterventions intothesepointsofcontact).

 Collaboratelocallywithpartners fromtheaddictionsandrecoverycommunities,researchers,public

healthauthorities,syringeservice programs, opioid substitutionproviders,andotheralliestosupport

increasedviralhepatitiseducation and services for peoplewho injectdrugs.

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



          

  



         

                 

      

               

   

              

        

               

 

                 

          

               

  

             

            

                



              



Priority Area 5

ReducingViralHepatitisCausedbyDrugUse

Stop the spread of viral hepatitis associated with drug use.

What steps can you/your organization take to ensure that persons who inject drugs have access to viral hepatitis

prevention, care, and treatment information and services?

Related Goal: Ensure that persons who inject drugs have access to viral hepatitis prevention, care, and

treatment services (Goal 5.1).

What can you/your organization do to develop and mobilize community resources to prevent viral hepatitis

associated with drug use/PWID, especially among young drug users?

Related Goal: Develop and mobilize community resources to prevent viral hepatitis caused by injection drug use

(Goal 5.2).

What roles can your organization play in expanding the provision of viral hepatitis information and access to and

delivery of hepatitis prevention, care, and treatment services in correctional settings?

Related Goal: Expand access to and delivery of hepatitis prevention, care, and treatment services in correctional

settings (Goal 5.3).

What are the opportunities for you/your organization to work with researchers and communities to

develop/implement strategies to improve prevention of viral hepatitis among persons who use drugs?

Related Goal: Advance re search to impr ove prevention of viral hepatitis among persons who use drugs (Goal 5.4).

Information, partners, materials or tools that would be helpful in Priority Area 5 efforts include:

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



          



  



  

   



      

              

             

            

             

  

   

  

 

  



  





  

 



           

   



 

  

 



     



Priority Area 6:

Protecting Patients From

Health Care‐Associated Viral Hepatitis

Quality health care is safe health care.

Neither patients nor providers should be at risk for acquiring HBV, HCV, or other bloodborne

infections during health care encounters. Stakeholders in the Action Plan recognize that such health

care‐associated infections are an important public health and patient safety issue and are

committed to better understanding the causes and further reducing the risk of their occurrence.

GOAL 6.1

Reducetransmissionof viralhepatitistopatientsresultingfrom misuse of medical

devicesanddrugs.

GOAL 6.2

Reducetransmissionof viralhepatitis associatedwithblood,organs,andtissues.

GOAL 6.3

Reduceoccupationaltransmissionof viralhepatitis.

GOAL 6.4

Enhanceunderstandingofthepreventablecausesof viralhepatitistransmissionin

healthcaresettings.

Opportunities for Stakeholders

Individuals can:

 Askhealthcareprovidersifa newneedle,newsyringe, anda newvialwillbeusedfor

proceduresorinjections.

 Askhealthcareprovidershowtheyprevent the spreadof infectionsintheirfacilities.

Public health, research, and other health professionals and professional organizations, associations, schools

and training programs can:

 Ensureinstitutional infectioncontrolandprevention policies are updated, clearlycommunicated,

andenforced.

 Updateandconductprovidertrainings ininfectioncontrol.

 Investinnewtechnologiesthat reducetransmissionof bloodbornepathogens.

 Vaccinateallhealthcareworkersfor hepatitisB.

 Implement measuresto prevent opioiddiversion.

 Developnew resources,tools,and technologiesthatreducethe likelihoodof health care‐associated

diseasetransmission.

 Conductresearchtoidentifytransmissionrisksandguidethedevelopment of improvedprocedures,

policies,andpractices.

Community‐based, patient and advocacy groups can:

 Disseminaterecommendations,guidelines,andcampaign materials toprofessionaland

institutional networks.

 Reportsuspectedhealthcare‐associatedoutbreaksandcollaboratewithpublichealthinvestigation

andresearchefforts.

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



          

  



      

               

      

               

  

               

  

              

             

     

         

            

        

              

  

             



Priority Area 6

Protecting Patientsand Workers FromHealthCare‐Associated ViralHepatitis

Quality health care is safe health care.

How can you/your organization contribute to reducing the transmission of viral hepatitis to patients in medical

settings and raise awareness about this issue?

Related Goal: Reduce transmission of viral hepatitis to patients resulting from misuse of medical devices and

drugs (Goal 6.1).

What can your organization do to promote viral hepatitis testing and awareness among potential blood, organ,

and tissue donors?

Related Goal: Reduce transmission of viral hepatitis associated with blood, organs, and tissues (Goal 6.2).

What opportunities do(es) you/your organization have to raise awareness about viral hepatitis prevention in

health care and other occupational settings?

Related Goal: Reduce occupational transmission of viral hepatitis (Goal 6.3).

What activities/strategies can you/your organization promote or support to better understand the preventable

causes of viral hepatitis transmission in health care settings?

Related Goal: Enhance understanding of the preventable causes of viral hepatitis transmission in health care

settings (Goal 6.4).

Information, partners, materials or tools that would be helpful in Priority Area 6 include:

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



                     

  



          

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence

      



 

          

         

             

Hepatitis Activity Planning Sheet: Please use the chart below to plan activities for your organization as they relate to Priority Areas 1‐6.

Priority Area __:

GOAL Proposed Activity Lead Staff Potential Partners

Initiation

Date

Anticipated

Completion

Date

Possible Measures

GOAL __ [Describe activity] [Add staff names] [Add partners list]

mm/dd/yy mm/dd/yy

[

Describe measure]

GOAL __ [Describe activity]

[Add staff names] [Add partners list]

mm/dd/yy mm/dd/yy

[

Describe measure]

GOAL __ [Describe activity]

[Add staff names] [Add partners list]

mm/dd/yy mm/dd/yy

[

Describe measure]

GOAL __ [Describe activity]

[Add staff names] [Add partners list]

mm/dd/yy mm/dd/yy

[

Describe measure]

GOAL __ [Describe activity]

[Add staff names] [Add partners list]

mm/dd/yy mm/dd/yy

[

Describe measure]

Make additional copies of this table as needed for activities in each Priority Area.



          



NOTES

STAKEHOLDERS’ WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence



 

        

         

   

STAKEHOLDERS’ WORKBOOK

Exploring Vital Roles and Opportunities to Break the Silence

Developed by the Office of HIV/AIDS and Infectious Disease Policy

for planning purposes only

Download
Save PDF to desktop

Email
Email completed PDF

Send for Signing
Email for others to sign

Print
Print document

NAME

Vhap-workbook-for-stakeholders STAKEHOLDERS WORKBOOK

View Audit Log
Print With Audit Log
Duplicate Document

Fill Online, Printable, Fillable, Blank Vhap-workbook-for-stakeholders STAKEHOLDERS’ WORKBOOK Form

Related forms

Fillable Vhap-workbook-for-stakeholders STAKEHOLDERS’ WORKBOOK

Fill Online, Printable, Fillable, Blank Vhap-workbook-for-stakeholders STAKEHOLDERS’ WORKBOOK Form

Related forms

First 20 documents completely FREE!